Ionis Pharmaceuticals, Inc. (IONS) FY2026 Q2 Balance Sheet

Ionis Pharmaceuticals, Inc. (IONS) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets

2,994,501,000 US dollars

Current assets

2,491,274,000 US dollars

Non-current assets

503,227,000 US dollars

Liabilities

2,554,764,000 US dollars

Current liabilities

315,638,000 US dollars

Non-current liabilities

2,239,126,000 US dollars

Equity

439,737,000 US dollars

Short-term investments

1,704,520,000 US dollars

Cash and cash equivalents

350,065,000 US dollars

Other current assets

327,011,000 US dollars

Contracts receivable

58,845,000 US dollars

Inventories

50,833,000 US dollars

Right-of-use assets

231,560,000 US dollars

Property, plant and equipment, net

155,131,000 US dollars

Deposits and other assets

116,536,000 US dollars

Accrued liabilities

115,778,000 US dollars

Current portion of deferred contract revenue

73,837,000 US dollars

Accrued compensation

50,293,000 US dollars

Accounts payable

47,704,000 US dollars

Other current liabilities

25,149,000 US dollars

Income taxes payable

2,877,000 US dollars

0 percent convertible senior notes due April 2026, net

0 US dollars

Convertible senior notes, net - 0% Notes due 2030

753,356,000 US dollars

Convertible senior notes, net - 1.75% Notes due 2028

569,255,000 US dollars

Liability related to sale of future royalties, net

562,574,000 US dollars

Long-term lease liabilities

262,476,000 US dollars

Long-term deferred contract revenue

63,030,000 US dollars

Long-term obligations

28,435,000 US dollars

Additional paid-in capital

3,311,837,000 US dollars

Common stock, $0.001 par value; 300,000,000 shares authorized, 165,636,792 and 163,304,875 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively

166,000 US dollars

Accumulated deficit

negative 2,838,369,000 US dollars

Accumulated other comprehensive loss

negative 33,897,000 US dollars

Gross equity (calculated)

3,312,003,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

• Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
• Treasury shares and other negative equity contributions reduce equity.